Gene Therapy in Cardiovascular Research

gene therapy in cardiovascular research

Gene Therapy in Cardiovascular Research

* Corresponding author: Arpad Tosaki, Department of Pharmacology, Faculty of Pharmacy, Health and Science Center, University of Debrecen, Debrecen, Hungary, Tel/Fax: +36-52-255586, E-mail: [email protected] © 2012 School of Pharmacy, Ahvaz Jundishapur University of Medical Sciences; Published by DocS. This is an Open Access article distributed under the terms of the Creative Commons ...

Cell Therapy in Cardiovascular Disease

  Recently, cell therapy has sparked a revolution in ischemic heart disease that will in the future help clinicians to cure patients. Earlier investigations in animal models and clinical trials have suggested that positive paracrine effects such as neoangiogenesis and anti-apoptotic can improve myocardial function. In this regard the Royan cell therapy center designed a few trials in collaborat...

Gene Therapy in Cardiovascular Disease

Gene therapy is defined as the transference of nucleic acids to somatic cells of an individual resulting in a therapeutic effect (Yla-Herttuala & Martin, 2000). Among the advantages of gene therapy over the existent modalities of treatment are: the selective treatment of affected tissues, the possibility of using locally endogenous proteins in cases where its systemic application would incur in...

cardiovascular gene therapy: advances and challenges

-